Edition:
United Kingdom

Syros Pharmaceuticals Inc (SYRS.OQ)

SYRS.OQ on NASDAQ Stock Exchange Global Select Market

8.99USD
15 Dec 2017
Change (% chg)

$0.01 (+0.11%)
Prev Close
$8.98
Open
$9.25
Day's High
$9.34
Day's Low
$8.86
Volume
151,333
Avg. Vol
82,836
52-wk High
$24.35
52-wk Low
$6.31

Latest Key Developments (Source: Significant Developments)

Syros Pharma Q3 loss per share $0.53
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Syros Pharmaceuticals Inc :Syros reports third quarter 2017 financial results and highlights accomplishments and upcoming milestones.Q3 loss per share $0.53.Q3 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S.  Full Article

Syros Pharmaceuticals Q2 loss per share $5.42
Monday, 15 Aug 2016 

Syros Pharmaceuticals Inc : Syros Pharmaceuticals reports second quarter 2016 financial results and provides business update .Q2 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S.  Full Article

Deerfield Management Company reports 8.97 pct passive stake in Syros Pharmaceuticals
Wednesday, 6 Jul 2016 

Syros Pharmaceuticals Inc : Deerfield Management Company, L.P. reports 8.97 pct passive stake in Syros Pharmaceuticals as of July 6, 2016 - SEC filing Source - http://bit.ly/29i9dkF Further company coverage: [SYRS.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Syros Pharmaceuticals Inc shares open at $15.00 in debut
Thursday, 30 Jun 2016 

:Syros Pharmaceuticals Inc shares open at $15.00 in debut, above IPO price of $12.50 per share.  Full Article

BRIEF-Syros Pharma Q3 loss per share $0.53

* Syros reports third quarter 2017 financial results and highlights accomplishments and upcoming milestones